Democratizing hedge fund level analysis tools for everyone
| Name | Millennium Pharmacon International Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Pharmaniaga International Corporation Sdn. Bhd. | 73.43 | 73.43 |
| Public < 5% | 16.85 | 16.85 |
| PT. Danpac Pharma | 9.72 | 9.72 |
| Aman Bhakti Pulungan | 0.0 | 0.0 |
| Drs. Zurbandi | 0.0 | 0.0 |
| Joefly Joesoef Bahroeny | 0.0 | 0.0 |
| Imam Fathorrahman | 0.0 | 0.0 |
| Sarah Azreen Binti Abdul Samat | 0.0 | 0.0 |
| Mohamad Fazly Bin Hassan | 0.0 | 0.0 |
| Zulkifli Bin Jafar | 0.0 | 0.0 |
| Treasury Shares | 0.0 | 0.0 |
| Source | 2022 | 2021 |
|---|---|---|
| 3260 | SDPC | F2 |
| 3261 | SDPC | F2 |
| 3262 | SDPC | F2 |
| 3263 | SDPC | F2 |
| 3264 | SDPC | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 1910 | SDPC | F2 |
| 1911 | SDPC | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.05 | # 1 / 15 |
| EV_EBITDA | 8.15 | # 7 / 15 |
| PER | 5.99 | # 1 / 15 |
| PBV | 0.69 | # 2 / 15 |
| DER | 2.86 | # 13 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 0.91779279279279 | # 11 / 15 |
| ROA % | 1.8599999999999999 | # 10 / 15 |
| ROE % | 11.48 | # 9 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2026 | 3.0 | 1.6 |
| 2025 | 2.0 | 1.3 |
| 2024 | 2.5 | 1.9 |
| 2023 | 2.0 | 1.3 |
| 2022 | 1.0 | 0.3 |
| 2021 | 0.5 | 0.4 |
| 2020 | 1.0 | 1.0 |
| 2019 | 3.0 | 2.9 |
| Timeframe | Performance |
|---|---|
| 1W % | 1.7 |
| 1Mo % | 1.1 |
| 3Mo % | -4.2 |
| 1Yr % | 43.8 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 9.63 | 36.98 T | 32.98 T | 38,958 B | 5,365 B | 3,839 B |
| SOHO | 20.50 | 15.29 T | 14.58 T | 10,725 B | 980 B | 746 B |
| TSPC | 8.24 | 12.76 T | 8.61 T | 14,220 B | 1,885 B | 1,550 B |
| SIDO | 16.01 | 10.68 T | 10.21 T | 2,933 B | 959 B | 667 B |
| MDLA | 6.59 | 2.91 T | 2.75 T | 16,342 B | 643 B | 442 B |
| KAEF | 123.99 | 2.56 T | 8.59 T | 9,403 B | 627 B | 21 B |